Shadowbox announces the results of a case study with Myriad Genetics
Shadowbox, a leading innovator in healthcare automation solutions, is excited to announce the results of a case study with leading genetic testing company, Myriad Genetics,...
Tag : genomic testing
KromaTiD Launches Pinpoint FISH™ DNA Probes
KromaTiD a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch...
Milwaukee-Area Family Invests $10 Million in Research
Medical College of Wisconsin Research Center Renamed in Mellowes Family Honor The Medical College of Wisconsin (MCW) has dedicated its Genomic Sciences and Precision Medicine Center as the Linda T. and...
IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge
IndyGeneUS plans to use the grant funding from Johnson & Johnson Innovation to Scale Blockchain-secured Genomic Data Marketplace and Proprietary GenēUS™ Discovery Platform Today, IndyGeneUS...
Updated Guidelines from the AUA Include Genomic Assays
“2022 Guidelines At-A-Glance, Prostate Edition” booklets available exclusively at Exact Sciences’ AUA2022 Booth (#647) in New Orleans, May 12-16 Exact Sciences Corp., a global leader in advanced...
Democratizing Genomics, Sequentify Raises $7M for DNA Sequencing
600% revenue growth rate, Sequentify supplies Next Generation Sequencing libraries and software for cancer diagnostics, carrier screening and COVID-19 surveillance Sequentify, a Weizmann Institute of...
OBiO Technology to Present Data on OVersatile™ Platform
OBiO Technology (Shanghai) Corp., Ltd. (‘OBiO’, SSE:688238.SH), a gene and cell therapy-focused biotechnology company, serving as a contract research organization for vectorology and functional genomics...
54gene Completes Initial Phase of Nigerian 100K Genome Project
54gene, the health technology company advancing African genomics research for improved global health outcomes, has through its non-profit initiative, theAfrican Centre for Translational Genetics (ACTG),...
Tempus signs agreement with the United States Department of VA NPOP
Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year agreement with the United States Department of Veterans Affairs (VA) National Precision...
Clue Genetics Acquires Rare Fungus Collection
Clue Genetics Inc. (Clue) has announced its acquisition of certain R&D assets of Mycosynthetix, Inc. (MSX), including its proprietary collection of approximately 50,000 diverse strains...